ARDTArdent Health, Inc.
Is the business good?
The checks split: earnings fully cash-backed (3.0×), but returns that lean on debt.
Operating profit is fully backed by cash. Conversion is improving vs a year ago.
Operating profit is falling even as sales grow, costs are outrunning the top line.
Leverage-amplified, a high assets-to-equity ratio does much of the work. ROE 11% = margin × turnover × leverage.
Unless marked, from derived.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. The F-score rewards improvement, so an already-elite company can score mid-pack.
How good a business is ARDT?
Ardent Health, Inc. earns 9.5% on the capital it employs against a 9.0% cost of capital, so the business is worth more the bigger it gets.
Return on invested capital · cost of capital 9.0% · 0.51 points above what the capital costs: growth creates value
- Operating margin
- 3.3%
Operating margin · Medical Care Facilities median 9.3% · 12 months to Q2 2026
- Cash conversion
- 3.05×
Cash conversion · 0.88× a year ago · operating cash flow covers the operating profit after tax
- Share count, year on year
- +1.1%
Share count, year on year · shareholders own a smaller slice than a year ago
| Year | Operating margin |
|---|---|
| FY2022 | 6.1% |
| FY2023 | 2.8% |
| FY2024 | 6.1% |
| FY2025 | 4.5% |
Details›
- Operating margin12 months to Q2 2026
- 3.3%
- Net margin12 months to Q2 2026
- 1.2%
- Revenue, trailing twelve months
- $6.41B
- Net income, trailing twelve months
- $78M
- Return on invested capitaloperating profit after tax ÷ debt + equity − cash
- 9.5%
Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.